Loading News...
Back to Dashboard

Abbott Laboratories (ABT)

Real-time intraday values

Market Overview

From:
To:
ABT Intraday
No data available
SymbolABT
IPO DateMar 17, 1980
CEOMr. Robert B. Ford
Full Time Employees122k
SectorHealthcare
IndustryMedical Devices
CountryUnited States
ExchangeNYSE
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The company offers generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, hypertriglyceridemia, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. It also provides laboratory and transfusion medicine systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion serology testing; molecular diagnostics polymerase chain reaction instrument systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, and detect and measure infectious agents; point of care systems; cartridges for testing blood gas, chemistry, electrolytes, coagulation, and immunoassay; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; and drug and alcohol test. In addition, the company offers pediatric and adult nutritional products and infant formula; rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; diabetes care products, such as glucose and blood glucose monitoring systems; and neuromodulation devices. The company was formerly known as Abbott Alkaloidal Company and changed its name to Abbott Laboratories in 1915. Abbott Laboratories was founded in 1888 and is based in Abbott Park, Illinois.
Performance
PeriodReturn %Value Change
1 Day
+1.14%
+1.17 US$
5 Days
-1.15%
-1.21 US$
1 Month
+0.18%
+0.19 US$
6 Months
+13.77%
+12.55 US$

Analyzing Market with AI

Evaluating the last 30 days of history and fundamental metrics of ABT...

Key Statistics
Market Cap
179.44B
P/E Ratio
38.55
Div Yield
2.43%
52W High
$132.03
52W Low
$81.97

Analyst Consensus

ConsensusStrong Buy
Bullish2485.7%
Neutral414.3%
Bearish00.0%

52W Analyst Price Targets

Min Target
$100.00
Max Target
$130.00
Current$103.68
Avg Target$118.52

Analyst Recommendations

Target Price:$118.52($100.00 - $130.00)
FirmRatingTarget PriceUpside PotentialDate
Wells FargoOverweight$120.00+15.74%10/23/2026
CitigroupBuy$122.00+17.67%10/22/2026
RBC CapitalOutperform$125.00+20.56%10/22/2026
Wells FargoOverweight$119.00+14.78%10/22/2026
JP MorganOverweight$118.00+13.81%10/22/2026
TD CowenBuy$118.00+13.81%10/22/2026
BairdOutperform$123.00+18.63%10/22/2026
BTIGBuy$125.00+20.56%10/22/2026
TD CowenBuy$135.00+30.21%10/16/2026
BarclaysOverweight$120.00+15.74%10/7/2026
Community Thoughts

Share your analysis and sentiment on ABT

Join the community to share your analysis